Researchers conducted a retrospective review of unintentionally retained guidewires that were voluntarily reported to The Joint Commission from October 2012 through March 2018. Guidewires are used to place catheters, tubes and other devices.
The study shows unintentional retention occurred during insertion of vascular catheters, devices used during surgery and drainage tubes.
In cases where the guidewire discovery period was known, 39.3 percent were identified after hospital discharge. In 76.7 percent of cases, the harm was categorized as unexpected additional care or extended stay. Additionally, four patients died due to unintentionally retained guidewires.
“Unintentionally retained guidewires remain a significant patient safety issue,” study authors concluded.
More articles on healthcare quality:
1 dead after Ebola treatment center attack in Congo
Iowa sees 1st pediatric flu death of 2018-19 season
10 top patient safety concerns for 2019, ranked by ECRI Institute
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
